Good afternoon all!
Looking to hear what standards others have employed for time based or milestone based QC on Phase 1 trials? For example do you only do a closeout QC, do you do a startup, conduct, and closeout but with a limited scope, etc…
I have seen everything from multiple milestones to only a close out QC, the challenge is often times Phase 1 studies start and stop in a matter of months. This is a small window to QC (completeness in particular). How do you handle this?
Thanks in advance!
David